These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 26202243)

  • 1. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
    Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
    O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
    J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
    Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a small-molecule entry inhibitor for filoviruses.
    Basu A; Li B; Mills DM; Panchal RG; Cardinale SC; Butler MM; Peet NP; Majgier-Baranowska H; Williams JD; Patel I; Moir DT; Bavari S; Ray R; Farzan MR; Rong L; Bowlin TL
    J Virol; 2011 Apr; 85(7):3106-19. PubMed ID: 21270170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process.
    Sokolova AS; Yarovaya OI; Zybkina AV; Mordvinova ED; Shcherbakova NS; Zaykovskaya AV; Baev DS; Tolstikova TG; Shcherbakov DN; Pyankov OV; Maksyutov RA; Salakhutdinov NF
    Eur J Med Chem; 2020 Dec; 207():112726. PubMed ID: 32905862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor.
    Cui Q; Du R; Anantpadma M; Schafer A; Hou L; Tian J; Davey RA; Cheng H; Rong L
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29584652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
    Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
    Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry.
    Schafer A; Xiong R; Cooper L; Nowar R; Lee H; Li Y; Ramirez BE; Peet NP; Caffrey M; Thatcher GRJ; Saphire EO; Cheng H; Rong L
    PLoS Pathog; 2021 Feb; 17(2):e1009312. PubMed ID: 33539432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.
    Panchal RG; Reid SP; Tran JP; Bergeron AA; Wells J; Kota KP; Aman J; Bavari S
    Antiviral Res; 2012 Jan; 93(1):23-9. PubMed ID: 22027648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.